Assessing Dynamic Breast Cancer Screening Policies

References

• Ali S. Female breast cancer incidence, stage at diagnosis, treatment, and mortality in North Carolina. (2006) . North Carolina Public Health State Center for Health Statistics Study No. 150. Raleigh, NCGoogle Scholar
• Althuis M., Borgan D., Coates R., Daling J., Gammon M., Malone K., Schoenberg J., Brenton L. Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 14:151–160Crossref, Google Scholar
• American Cancer SocietyBreast Cancer Facts and Figures 2005–2006, Table 7. Mammography, Women 40 and Older, US, 2003 (2005a) (American Cancer Society, Inc., Atlanta) 15Google Scholar
• American Cancer SocietyBreast Cancer Facts and Figures 2005–2006 (2005b) (American Cancer Society, Inc., Atlanta) 28Google Scholar
• American Cancer SocietyBreast Cancer Facts and Figures 2005–2006 (2006) (American Cancer Society, Inc., Atlanta) 2Google Scholar
• Baker R. Use of a mathematical model to evaluate breast cancer screening policy. Health Care Management Sci. (1998) 1:103–113Crossref, Google Scholar
• Beemsterboer P. Evaluation of screening programmes. (1999) . Ph.D. dissertation, Department of Public Health, Erasmus University, Rotterdam, The NetherlandsGoogle Scholar
• Berry D. A., Cronin K. A., Plevritis S. K., Fryback D., Clarke L., Zelen M., Mandelblatt J. S., Yakovlev A. Y., Habbema J. D. F., Feuer E. J. Effect of screening and adjuvant therapy on mortality from breast cancer. New England J. Medicine (2005) 353:1784–1792Crossref, Google Scholar
• Blanchard K., Colbert J., Purl D., Welssman J., Moy B., Kopans D., Kalne E., Moore R., Halpern E., Hughes K., Tanabe K., Smith B., Michaelson J. Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival. Cancer (2004) 101(3):495–507Crossref, Google Scholar
• Bloom H., Richardson W., Harries E. Natural history of untreated breast cancer (1805–1933). British Medical J. (1962) 2(July 28):213–221Crossref, Google Scholar
• Breast Cancer Surveillance Consortium Performance measures for 2,585,218 screening mammography examinations from 1996 to 2002 by age. (2006) . U.S. National Institutes of Health, National Cancer Institute, Bethesda, MDGoogle Scholar
• Brenner H., Hakulinen T. Are patients diagnosed with breast cancer before age 50 years ever cured? J. Clinical Oncology (2004) 22(3):432–438Crossref, Google Scholar
• CDC: U.S. Department of Health and Human Services Centers for Disease Control (CDC) and Prevention Table 3: Number of deaths and death rates, by age, race, and sex: United States, 2003, National Vital Statistics Reports 53(5), National Center for Health Statistics. (2004) . Released October 12, 2004Google Scholar
• Carney P., Miglioretti D., Yankaskas B., Kerlikowske K., Rosenberg R., Rutter C., Geller B., Abraham L., Taplin S., Dignan M., Cutter G., Ballard-Barbash R. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann. Internal Medicine (2003) 138:168–175Crossref, Google Scholar
• De Koning H. The effects and costs of breast cancer screening. (1993) . Ph.D. dissertation, Department of Public Health, Erasmus University, Rotterdam, The NetherlandsGoogle Scholar
• Elmore J., Barton M., Moceri V., Polk S., Arena P., Fletcher S. Ten-year risk of false positive screening mammograms and clinical breast examinations. New England J. Medicine (1998) 338(16):1089–1096Crossref, Google Scholar
• Foxcroft L., Evans E., Porter A. The diagnosis of breast cancer in women younger than 40. The Breast (2004) 13:297–306Crossref, Google Scholar
• Fryback D. G., Stout N. K., Rosenberg M. A., Trentham-Dietz A., Kuruchittham V., Remington P. L. The Wisconsin breast cancer epidemiology simulation model. J. Natl. Cancer Institute Monographs (2006) 26:37–47Crossref, Google Scholar
• Genetics of Breast and Ovarian Cancer (PDQ®) (2006) . Health professional version, U.S. National Institutes of Health, National Cancer Institute, Bethesda, MD. www.cancer.gov; last updated 11/11/06Google Scholar
• Ivy J. A maintenance model for breast cancer treatment and detection. (2008) . Working paper, Edward P. Fitts Department of Industrial and Systems Engineering, North Carolina State University, Raleigh, NCGoogle Scholar
• Kirch R., Klein M. Surveillance schedules for medical examinations. Management Sci. (1974) 20(10):1403–1409Link, Google Scholar
• Kroman N., Jensen M., Wohlfahrt J., Mouridsen H., Andersen P., Melbye M. Factors influencing the effect of age on prognosis in breast cancer: Population based study. British Medical J. (2000) 320:474–479Crossref, Google Scholar
• Lee S., Zelen M. Scheduling periodic examinations for the early detection of disease: Applications to breast cancer. J. Amer. Statist. Assoc. (1998) 93(444):1271–1281Crossref, Google Scholar
• Lee S., Zelen M. Modelling the early detection of breast cancer. Ann. Oncology (2003) 14:1199–1202Crossref, Google Scholar
• Lee S., Huang H., Zelen M. Early detection of disease and scheduling of screening examinations. Statist. Methods Medical Res. (2004) 13:443–456Crossref, Google Scholar
• Mathew A., Rajan B., Pandey M. Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis? World J. Surgical Oncology (2004) 2:1–7Crossref, Google Scholar
• Menopause Guidebook (2006) 6th ed.(The North American Menopause Society, Cleveland) . http://www.menopause.orgGoogle Scholar
• Michaelson J., Halpern E., Kopans D. Breast cancer: Computer simulation method for estimating optimal intervals for screening. Radiology (1999) 212:551–560Crossref, Google Scholar
• Moss S. Should women under 50 be screened for breast cancer? British J. Cancer (2004) 91:413–417Crossref, Google Scholar
• Ozekici S., Pliska S. Optimal scheduling of inspections: A delayed Markov model with false positive and negatives. Oper. Res. (1991) 39(2):261–273Link, Google Scholar
• Parmigiani G. On optimal screening ages. J. Amer. Statist. Assoc. (1993) 88(422):622–628Crossref, Google Scholar
• Peer P., van Dijck J., Hendricks J., Holland R., Verbeek A. Age-dependent growth of primary breast cancer. Cancer (1993) 71:3547–3551Crossref, Google Scholar
• Pisano E. Diagnostic performance of digital versus film mammography for breast-cancer screening. New England J. Medicine (2005) 353:1773–1783Crossref, Google Scholar
• Schairer C., Mink P., Carroll L., Devesa S. Probabilities of death from breast cancer and other causes among female breast cancer patients. (2004) 96(17):1311–1321Google Scholar
• SEER: Surveillance, Epidemiology, and End Results (SEER) Cancer statistics review 1975–2002. J. National Cancer Institute (2005) AprilGoogle Scholar
• Shwartz M. A mathematical model used to analyze breast cancer screening strategies. Oper. Res. (1978) 26(6):937–955Link, Google Scholar
• Sibbering D., Burrell H., Evans A., Yeoman L., Wilson A., Robertson J., Blamey R. Mammographic sensitivity in women under 50 years presenting symptomatically with breast cancer. Breast (1995) 4:127–129Crossref, Google Scholar
• Smith R., Saslow D., Sawyer K., Burke W., Costanza M., Evans W., Foster R., Hendrick E., Eyre H., Sener S. American Cancer Society guidelines for breast cancer screening: Update 2003. CA A Cancer J. Clinicians (2003) 53(3):141–169Crossref, Google Scholar
• Stages of Breast Cancer (2007) . http://www.breastcancer.org/dia_pict_staging.htmlGoogle Scholar
• Szeto K., Devlin N. The cost-effectiveness of mammography screening: Evidence from a microsimulation model for New Zealand. Health Policy (1996) 38:101–115Crossref, Google Scholar
• Tabar L., Vitak B., Chen H., Duffy S., Yen M., Chiang C., Krusemo U., Tot T., Smith R. The Swedish two-county trial twenty years later: Updated mortality results and new insights from longterm follow-up. Breast Imaging (2000) 38(4):625–651Google Scholar
• U.S. Department of Health and Human Services Centers for Disease Control and PreventionThe National Breast and Cervical Cancer Early Detection Program At-A-Glance 1995 (1995) . U.S. Department of Health and Human Services Centers for Disease Control and Prevention, AtlantaGoogle Scholar
• U.S. Department of Health and Human Services Centers for Disease Control and PreventionThe National Breast and Cervical Cancer Early Detection Program At-A-Glance 2000 (2000) 2U.S. Department of Health and Human Services Centers for Disease Control and Prevention, AtlantaGoogle Scholar
• Warwick J., Duffy S. W. A review of cancer screening evaluation techniques, with some particular examples in breast cancer screening. J. Roy. Statist. Assoc. (2005) 168:657–677Crossref, Google Scholar
• Zelen M. Optimal scheduling of examinations for the early detection of disease. Biometrika (1993) 80(2):279–293Crossref, Google Scholar